Cornercap Investment Counsel Inc Amgen Inc Transaction History

Cornercap Investment Counsel Inc

$600 Million
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $47,415 - $57,792	210 Added 2.38%	9,028 $2.18 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $181,162 - $230,188	-791 Reduced 8.23%	8,818 $2.32 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $100,782 - $113,664	-449 Reduced 4.46%	9,609 $2.17 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $134,273 - $149,422	582 Added 6.14%	10,058 $2.45 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $98,013 - $108,428	447 Added 4.95%	9,476 $2.29 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $132,652 - $151,809	-667 Reduced 6.88%	9,029 $2.03 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $62,619 - $73,366	-295 Reduced 2.95%	9,696 $2.06 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $33,168 - $36,797	-142 Reduced 1.4%	9,991 $2.44 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $2.25 Million - $2.62 Million	10,133 New	10,133 $2.52 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $2.15 Million - $2.56 Million	-9,947 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $3,754 - $4,175	16 Added 0.16%	9,947 $2.53 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $1.96 Million - $2.41 Million	9,931 New	9,931 $2.34 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $5.87 Million - $7.03 Million	-33,714 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $63,012 - $73,864	-378 Reduced 1.11%	33,714 $6.21 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $45,760 - $51,581	-253 Reduced 0.74%	34,092 $6.48 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $288,651 - $336,948	-1,618 Reduced 4.5%	34,345 $6.69 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $214,936 - $242,312	-1,160 Reduced 3.12%	35,963 $7.46 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $182,655 - $205,161	-1,100 Reduced 2.88%	37,123 $6.85 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $190,947 - $223,146	-1,127 Reduced 2.86%	38,223 $6.52 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $4,894 - $5,469	-29 Reduced 0.07%	39,350 $6.84 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $6.59 Million - $7.52 Million	39,379	39,379 $7.34 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Account